Dr. Mccormack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Eden Ave
Cincinnati, OH 45220Phone+1 513-475-8523Fax+1 513-475-1327
Summary
- Dr. Francis Mccormack is a pulmonologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including University of Cincinnati Medical Center, Cincinnati Veterans Affairs Medical Center, Daniel Drake Center for Post Acute Care, and Cincinnati Children's Hospital Medical Center. He received his medical degree from University of Texas Medical Branch and has been in practice 35 years. He specializes in interstitial lung diseases and pleural disease and is experienced in interstitial lung disease, lymphangioleiomyomatosis, critical care medicine, and rare lung diseases.
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
- University of MichiganChief Residency, Internal Medicine, 1985 - 1986
- University of MichiganResidency, Internal Medicine, 1982 - 1985
- University of Texas Medical Branch School of MedicineClass of 1982
Certifications & Licensure
- OH State Medical License 1994 - 2026
- CO State Medical License 1986 - 1995
- MI State Medical License 1985 - 1992
- TX State Medical License 1983 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2016
- Elected Member Alpha Omega Alpha, 2012
- Top 10 US Clinicial Research Achievements of 2011 Clinical Research Forum, 2011
- Join now to see all
Clinical Trials
- Efficacy and Safety of Sirolimus in LAM Start of enrollment: 2006 Dec 01
- Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Start of enrollment: 2009 Apr 01
- Letrozole for Lymphangioleiomyomatosis Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 266 citationsUpdated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.Hope Northrup, Mary E. Aronow, E. Martina Bebin, John Bissler, Thomas N. Darling
Pediatric Neurology. 2021-07-24 - 36 citationsThe 85-kDa, arachidonic acid-specific phospholipase A2 is expressed as an activated phosphoprotein in Sf9 cells.M.S. Decarvalho, Francis X. McCormack, C.C. Leslie
Archives of Biochemistry and Biophysics. 1993-11-01 - 5 citationsSafety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis.Nishant Gupta, Bin Zhang, Yuan Zhou, Francis X McCormack, Rebecca Ingledue
Chest. 2023-05-01
Journal Articles
- The Vitamin D Binding Protein Axis Modifies Disease Severity in LymphangioleiomyomatosisFrancis Mccormack, MD, The European Respiratory Journal
- efficacy and safety of sirolimus
Press Mentions
- Innovative Imaging, Surgery Treats Lymph Condition in AdultsJanuary 10th, 2017
Grant Support
- Lung and Cardiovascular Development and Disease Pathogenesis Training ProgramNational Heart, Lung and Blood Institute2015–2020
- Pathogenesis-Driven Therapeutic Development for Pulmonary Alveolar MicrolithiasisNational Heart, Lung and Blood Institute2015–2019
- Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung DiseasesNational Heart, Lung and Blood Institute2014–2019
- KGF-Modulation of Burn Induced Lung Injury and InfectionShriner’s of North America2013–2018
- Therapeutic strategy for Lymphangioleiomyomatosis (LAM) and Tuberous SclerosisNational Heart Lung and Blood Institute2013–2016
Committees
- Member, FDA Pulmonary and Allergy Drug Advisory Committee 2013 - 2015
- Member, American Board of Internal Medicine Pulmonary Board 2013 - 2015
- Member, Department of Defense Tuberous Sclerosis Program Vision Setting Committee 2012 - 2015
Professional Memberships
- Fellow
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: